632 related articles for article (PubMed ID: 15866551)
1. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
Caspi A; Moffitt TE; Cannon M; McClay J; Murray R; Harrington H; Taylor A; Arseneault L; Williams B; Braithwaite A; Poulton R; Craig IW
Biol Psychiatry; 2005 May; 57(10):1117-27. PubMed ID: 15866551
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
[TBL] [Abstract][Full Text] [Related]
3. Cannabis, COMT and psychotic experiences.
Zammit S; Owen MJ; Evans J; Heron J; Lewis G
Br J Psychiatry; 2011 Nov; 199(5):380-5. PubMed ID: 21947654
[TBL] [Abstract][Full Text] [Related]
4. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
[TBL] [Abstract][Full Text] [Related]
5. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
[TBL] [Abstract][Full Text] [Related]
6. COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.
Collip D; van Winkel R; Peerbooms O; Lataster T; Thewissen V; Lardinois M; Drukker M; Rutten BP; Van Os J; Myin-Germeys I
CNS Neurosci Ther; 2011 Dec; 17(6):612-9. PubMed ID: 21073668
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use, COMT, BDNF and age at first-episode psychosis.
Mané A; Bergé D; Penzol MJ; Parellada M; Bioque M; Lobo A; González-Pinto A; Corripio I; Cabrera B; Sánchez-Torres AM; Saiz-Ruiz J; Bernardo M;
Psychiatry Res; 2017 Apr; 250():38-43. PubMed ID: 28142064
[TBL] [Abstract][Full Text] [Related]
9. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
[TBL] [Abstract][Full Text] [Related]
10. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis.
Bioque M; Mas S; Costanzo MC; Cabrera B; Lobo A; González-Pinto A; Rodriguez-Toscano E; Corripio I; Vieta E; Baeza I; Ibáñez Á; Fraile MG; Cuesta MJ; Mezquida G; Lafuente A; Bernardo M;
Eur Neuropsychopharmacol; 2019 Jun; 29(6):786-794. PubMed ID: 31076188
[TBL] [Abstract][Full Text] [Related]
11. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
[TBL] [Abstract][Full Text] [Related]
13. Adolescent cannabis use, psychosis and catechol-O-methyltransferase genotype in African Americans and Caucasians.
Kantrowitz JT; Nolan KA; Sen S; Simen AA; Lachman HM; Bowers MB
Psychiatr Q; 2009 Dec; 80(4):213-8. PubMed ID: 19633959
[TBL] [Abstract][Full Text] [Related]
14. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
[TBL] [Abstract][Full Text] [Related]
15. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.
Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E
J Affect Disord; 2010 Sep; 125(1-3):341-4. PubMed ID: 20122740
[TBL] [Abstract][Full Text] [Related]
16. Evidence that environmental and genetic risks for psychotic disorder may operate by impacting on connections between core symptoms of perceptual alteration and delusional ideation.
Smeets F; Lataster T; Viechtbauer W; Delespaul P;
Schizophr Bull; 2015 May; 41(3):687-97. PubMed ID: 25217481
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyltransferase Val158Met polymorphism and clinical characteristics in first episode non-affective psychosis.
Pelayo-Terán JM; Crespo-Facorro B; Carrasco-Marín E; Pérez-Iglesias R; Mata I; Arranz MJ; Leyva-Cobián F; Vázquez-Barquero JL
Am J Med Genet B Neuropsychiatr Genet; 2008 Jul; 147B(5):550-6. PubMed ID: 18092319
[TBL] [Abstract][Full Text] [Related]
18. Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences.
Tunbridge EM; Dunn G; Murray RM; Evans N; Lister R; Stumpenhorst K; Harrison PJ; Morrison PD; Freeman D
J Psychopharmacol; 2015 Nov; 29(11):1146-51. PubMed ID: 26464454
[TBL] [Abstract][Full Text] [Related]
19. Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.
Batalla A; Soriano-Mas C; López-Solà M; Torrens M; Crippa JA; Bhattacharyya S; Blanco-Hinojo L; Fagundo AB; Harrison BJ; Nogué S; de la Torre R; Farré M; Pujol J; Martín-Santos R
Addict Biol; 2014 Jul; 19(4):722-32. PubMed ID: 23311613
[TBL] [Abstract][Full Text] [Related]
20. The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.
Vaessen TSJ; de Jong L; Schäfer AT; Damen T; Uittenboogaard A; Krolinski P; Nwosu CV; Pinckaers FME; Rotee ILM; Smeets APW; Ermiş A; Kennedy JL; Nieman DH; Tiwari A; van Os J; Drukker M
PLoS One; 2018; 13(2):e0192658. PubMed ID: 29444152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
